Anzeige
❌
Mehr »
Sonntag, 22.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DLB7 | ISIN: CA88337V1004 | Ticker: TTX
Frankfurt
20.11.26 | 08:05
0,108 Euro
+1,89 % +0,002
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERALASE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
THERALASE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1030,12421.11.

Aktuelle News zur THERALASE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
THERALASE Aktie jetzt für 0€ handeln
26.10.Theralase Technologies Inc: Theralase talks 64.5% response in bladder study5
26.10.Theralase Technologies Inc.: Theralase Provides Bladder Cancer Clinical Study Update269Toronto, Ontario--(Newsfile Corp. - October 26, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical-stage pharmaceutical company dedicated to the...
► Artikel lesen
09.10.Theralase Technologies Inc.: Theralase(R) to Present at ThinkEquity Conference387Toronto, Ontario--(Newsfile Corp. - October 9, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical-stage pharmaceutical company dedicated to the...
► Artikel lesen
18.09.Theralase Technologies Inc.: Theralase(R) Releases Q2 2026 Financial Statements850Toronto, Ontario--(Newsfile Corp. - September 18, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical-stage pharmaceutical company dedicated to...
► Artikel lesen
15.09.Theralase Technologies Inc: Theralase begins GLP toxicology analysis of Rutherrin2
15.09.Theralase Technologies Inc.: Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)484Successful completion of GLP toxicology analysis for the intravenous administration of Rutherrin(R) lays the groundwork for regulatory submissions supporting first-in-human clinical development for...
► Artikel lesen
05.09.Theralase Technologies Inc: Theralase private placement, warrant listing2
28.08.Theralase Technologies Inc. reports 1H results6
25.08.Theralase Technologies Inc: Theralase Technologies closes $3.55-million financing3
24.08.Theralase Technologies Inc.: Theralase(R) Closes C$3.6 Million Brokered Financing582Toronto, Ontario--(Newsfile Corp. - August 24, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to...
► Artikel lesen
11.08.Theralase Technologies Inc: Theralase arranges minimum $3-million private placement5
10.08.Theralase launches C$5M private placement1
10.08.Theralase Technologies Inc.: Theralase(R) Announces $5 Million Brokered LIFE Offering3.611Toronto, Ontario--(Newsfile Corp. - August 10, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to...
► Artikel lesen
07.08.Theralase Technologies Inc.: Theralase(R) Grants Stock Options950Toronto, Ontario--(Newsfile Corp. - August 7, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to...
► Artikel lesen
04.08.Theralase Technologies Inc: Theralase hires Global One Media for marketing services3
04.08.Theralase Technologies Inc.: Theralase(R) Engages Global One Media to Expand Global Investor Awareness399Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to...
► Artikel lesen
01.07.Theralase Technologies Inc: Theralase obtains receipt for final prospectus11
30.06.Theralase Technologies Inc.: Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus575Toronto, Ontario--(Newsfile Corp. - June 30, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to the...
► Artikel lesen
03.06.Theralase Technologies Inc: Theralase to list warrants on TSX-V June 91
03.06.Theralase Technologies Inc.: Theralase(R) Lists Warrants on the TSXV312Toronto, Ontario--(Newsfile Corp. - June 3, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage pharmaceutical company dedicated to the...
► Artikel lesen
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1